Abstract:The human immunodeficiency virus (HIV) envelope protein (Env) mediates viral entry into host cells and is the primary target for the humoral immune response. Env is extensively glycosylated, and these glycans shield underlying epitopes from neutralizing antibodies. The glycosylation of Env is influenced by the type of host cell in which the virus is produced. Thus, HIV is distinctly glycosylated by CD4 + T cells, the major target cells, and macrophages. However, the specific differences in glycosylation between viruses produced in these cell types have not been explored at the molecular level. Moreover, it remains unclear whether the production of HIV in CD4 + T cells or macrophages affects the efficiency of viral spread and resistance to neutralization. To address these questions, we employed the simian immunodeficiency virus (SIV) model. Glycan analysis implied higher relative levels of oligomannose-type N -glycans in SIV from CD4 + T cells (T-SIV) compared to SIV from macrophages (M-SIV), and the complex-type N -glycans profiles seem to differ between the two viruses. Notably, M-SIV demonstrated greater infectivity than T-SIV, even when accounting for Env incorporation, suggesting that host cell-dependent factors influence infectivity. Further, M-SIV was more efficiently disseminated by HIV binding cellular lectins. We also evaluated the influence of cell type-dependent differences on SIV's vulnerability to carbohydrate binding agents (CBAs) and neutralizing antibodies. T-SIV demonstrated greater susceptibility to mannose-specific CBAs, possibly due to its elevated expression of oligomannose-type N -glycans. In contrast, M-SIV exhibited higher susceptibility to neutralizing sera in comparison to T-SIV. These findings underscore the importance of host cell-dependent attributes of SIV, such as glycosylation, in shaping both infectivity and the potential effectiveness of intervention strategies. The human immunodeficiency virus (HIV) is the causative agent of the acquired immunodeficiency syndrome (AIDS), a lethal condition that necessitates life-long antiretroviral therapy for prevention. The envelope protein (Env) of HIV mediates the viral entry into host cells and is the sole target for the immune system on the surface of the virus. Env's extensive modification with sugars, so called N -glycans, shields crucial epitopes from neutralizing antibodies. Interestingly, key HIV producing cell types, such as CD4 + T cells and macrophages, modify Env with distinct N -glycosylation patterns. However, the specific molecular disparities in N -glycosylation between viruses from these cell types are unexplored, and whether the producer cell type impacts the viral spread and resistance to neutralization is incompletely understood. Utilizing the simian immunodeficiency virus (SIV) as a model for HIV, our study revealed differing N -glycan profiles between SIV Env produced in CD4 + T cells (T-SIV) and macrophages (M-SIV), with T-SIV incorporating more N -glycans of the oligomannose-type into Env than M-SIV. M-SIV displayed enhanced infectivity and transmissibility in in vitro studies. Additionally, M-SIV exhibited greater susceptibility to neutralizing sera compared to T-SIV, while T-SIV showed heightened susceptibility to mannose-specific carbohydrate-binding agents. These findings emphasize the critical role of host cell-dependent attributes in shaping N -glycosylation of Env as well as viral infectivity and spread. These findings have important implications for the development of new biomedical interventions against HIV.

The Human and Simian Immunodeficiency Viruses HIV-1, HIV-2 and SIV Interact with Similar Epitopes on Their Cellular Receptor, the CD4 Molecule.

Role of Interleukin-4 and Monocyte Chemoattractant Protein-1 in the Neuropathogenesis of X4 Simian Human Immunodeficiency Virus Infection in Macaques

Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.

Expression cloning of new receptors used by simian and human immunodeficiency viruses

Envelope Glycoproteins from Human Immunodeficiency Virus Types 1 and 2 and Simian Immunodeficiency Virus Can Use Human CCR5 As a Coreceptor for Viral Entry and Make Direct CD4-dependent Interactions with This Chemokine Receptor

Macrophage- and CD4 T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity

Macrophage- and CD4 + T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity

Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.

In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5

CD4-mimetic Small Molecules Sensitize Human Immunodeficiency Virus to Vaccine-Elicited Antibodies.

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

The T Cell Receptor Gene Usage By Simian Immunodeficiency Virus Gag-Specific Cytotoxic T Lymphocytes In Rhesus Monkeys

Recognition of HIV-1 Peptides by Host CTL is Related to HIV-1 Similarity to Human Proteins.

Cellular Cd44s As A Determinant of Human-Immunodeficiency-Virus Type-1 Infection and Cellular Tropism

Loss of CD4 Membrane Expression and CD4 Mrna During Acute Human Immunodeficiency Virus Replication.

A Common Immunological Epitope Existing between HIV-1 gp41 and Human Interferon-α and -β

HIV-1 Gp41 and Type I Interferon: Sequence Homology and Biological As Well As Clinical Implications.

Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1.

Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.

CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair

Envelope Residue 375 Substitutions in Simian–human Immunodeficiency Viruses Enhance CD4 Binding and Replication in Rhesus Macaques